Gene Therapy is now touted as a new revolution for cancer treatment. If the list of new cancer treatment methodologies is traversed, then the end seems to be farther and farther away. As a sequel t...
SNAPSHOTS: Copiktra receives FDA approval for CLL and FL, Relief for tazemetostat developers after FDA lifted partial clinical hold, Conference highlights from 19th WCLC The United States Food and Drug Administration (USFDA) has granted approval to Verastem’s Copiktra (duvelisib), for the treatment of patients with...
Find More
Orchard files for USD173 Million IPO to run pivotal gene therapy trials Orchard Therapeutics, Transatlantic biotech, has filed to raise USD 173 million in an IPO. This will lead it to take three gene therapies through the clinic. Orchard recognised itself as one of the broadest clinical-phase gene therapy pipelines ...
Find More
Laser Interstitial Thermal Therapy (LITT) is one of a hopeful treatment for brain cancer. Now, researchers are also using lasers to activate cancer-destroying drugs and other groups are testing the use of electrical fields to intersect the cancer cells division. The researchers are yet to determine the effectiveness...
Find More
DelveInsight's Infographic: Breast Cancer Precautions because October is the Breast Cancer Awareness Month. #breastcancer #cancer #infographic Apart from these precautions, women above 20 should start doing monthly self-breast examinations that can help in early detection of this disease. Hope that we can change...
Find More
Hologic complements Focal Therapeutics to its breast-conserving surgery for USD 125 Million Hologic, a global champion of women's health based in Massachusetts, United States, is taking possession of Focal Therapeutics, a medical device company, for USD 125 million to complement its breast-conserving surgery permit...
Find More
Companion diagnostics domain falls within the larger field of study called pharmacogenomics, which employs the person’s genomic makeup to predict a drug response or to tailor therapy specifically for that patient. The US FDA depicts companion diagnostics as an in vitro diagnostic device or an imaging tool, which pro...
Find More
The interleukin-33 antibody of AnaptysBio passes midstage test in asthma The pipeline drug, etokimab of AnaptysBio, has positive data in a third indication that adds asthma to one of its triumphs. The US-based company gets another proof-of-concept study for the interleukin-33 (IL-33) inhibitor, because of phase 2a ...
Find More
Cancer treatment methodologies are always evolving, and there cannot be any denying to the fact. In this uninterrupted pursuit, old formulas are sometimes used in new ways, arousing hopes for patients as well as commercial treatment providers. A case in point is the usage of light, which has long been used to see ca...
Find More
Herpes zoster oticus (HZ oticus) is a viral infection of the inner, middle, and external ear. A resu.....
Find More
Vitiligo is a chronic complex pigment disorder where pale white patches develop on the skin. Any loc.....
Find More
Immunotherapies, a potentially life-saving therapy, have benefitted several patients suffering from .....
Find More
Wearable technology has been gaining momentum for the last few years as an effect of the fourth indu.....
Find More-Agonist.png)
Toll-like Receptors (TLRs) are a type of pattern recognition receptor (PRR) that recognizes pathogen.....
Find More
Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease that results in systemic inflamma.....
Find More-Agonist.png "Toll-like Receptors Agonist")
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
